Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Implementation Ratika Parkash, MD, MSc, François Philippon,

Slides:

Advertisements

Similar presentations

Copyright © 2013, Canadian Cardiovascular Society 13/11/ Anderson TJ, Gregoire J et al., Can J Cardiol 2013 Feb;29(2): Disclaimer The Canadian.

Advertisements

Sex- and Gender-Related Risk Factor Burden in Patients With Premature Acute Coronary Syndrome Jin Choi, MSc, Stella Styliani Daskalopoulou, MD, MSc, PhD,

Dual-site right ventricular and left ventricular pacing in a patient with left ventricular systolic dysfunction and atrial fibrillation using a standard.

Utilization of a national network for rapid response to the Medtronic Fidelis lead advisory: The Canadian Heart Rhythm Society Device Advisory Committee.

Canadian Cardiovascular Society/Canadian Anesthesiologists' Society/Canadian Heart Rhythm Society Joint Position Statement on the Perioperative Management.

Current and Future Status of Extracorporeal Cardiopulmonary Resuscitation for In- Hospital Cardiac Arrest Rohit K. Singal, MD, MSc, Deepa Singal, MSc,

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

Fig ACCF/AHA Guideline for the management of heart failure

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotensinconvertingenzyme; ARB, angiotensin receptor blocker; CRT-D,

Comparison of Low Versus High (>40 mm Hg) Pulse Pressure to Predict the Benefit of Cardiac Resynchronization Therapy for Heart Failure (from the Multicenter.

Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:

Influence of Diabetes on Cardiac Resynchronization Therapy With or Without Defibrillator in Patients With Advanced Heart Failure Jalal k. Ghali, MD,

Management of mitral regurgitation. See legend for Fig

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker;

Kiran Sidhu, MD, FRCPC, Anthony Tang, MD, FRCPC

Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation James A. Stone, MD,

The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice Jonathan G. Howlett, MD, FRCPC, Michael Chan, MBBS,

171 The risk stratification and stroke prevention therapy care gap in canadian atrial fibrillation patients: Insights from the Facilitating Review and.

A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.

A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.

Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on.

The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines Laurent Macle, MD,

2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Laurent Macle, MD, John Cairns, MD, Kori.

Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control

Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation Lena Rivard, MD, MSc, Paul Khairy, MD,

Canadian Cardiovascular Society/Canadian Anesthesiologists' Society/Canadian Heart Rhythm Society Joint Position Statement on the Perioperative Management.

Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Evidence and Patient Selection Derek V. Exner, MD, MPH, David.

Erratum Heart Rhythm Volume 8, Issue 4, (April 2011)

The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice Jonathan G. Howlett, MD, FRCPC, Michael Chan, MBBS,

Volume 11, Issue 9, Pages (September 2014)

José L. Morales et al. JACEP 2017;j.jacep

Sandra Lauck, RN, PhD, Dion Stub, MD, PhD, John Webb, MD

Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines Matthew Bennett, MD (Co-Chair),

Volume 9, Issue 8, Pages S3-S13 (August 2012)

Gaurav A. Upadhyay, MD, Jonathan S. Steinberg, MD Heart Rhythm

David D. Berg et al. JACC 2018;71:

Sexual Activity and Chronic Heart Failure

Gregory Y.H. Lip, MD, Jonathan L. Halperin, MD, Hung-Fat Tse, MD, PhD

The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines Laurent Macle, MD,

Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.

Health Care Use and Associated Time and Out of Pocket Expenditures for Patients With Cardiovascular Disease in a Publicly Funded Health Care System Saba.

Ethnic and racial disparities in cardiac resynchronization therapy

Volume 14, Issue 12, Pages (December 2017)

Volume 15, Issue 1, Pages (January 2018)

Shannon M. Dunlay, MD, MS, Naveen L. Pereira, MD, Sudhir S

Amy C. Arnold, PhD, MSCI, Satish R. Raj, MD, MSCI

Volume 6, Issue 4, Pages (April 2009)

Volume 14, Issue 12, Pages (December 2017)

Volume 9, Issue 8, Pages S14-S17 (August 2012)

Volume 5, Issue 5, Pages (May 2008)

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

Emilce Trucco et al. JACEP 2018;j.jacep

Appropriate use of genetics in a young patient with atrioventricular block and family history of sudden cardiac death Johnni Rudbeck-Resdal, MD, Jens.

Isolated right ventricular failure and abnormal hemodynamics caused by right ventricular pacing are reversed with cardiac resynchronization therapy Milena.

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Catheter Ablation for Atrial Fibrillation/Atrial Flutter Atul Verma, MD, FRCPC,

Michael H. Chiu, MD, Msc, Nakul C. Sharma, MD, MPH CJC Open

Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 2: ST-Segment Elevation.

Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on.

Erratum Canadian Journal of Cardiology

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Rate and Rhythm Management Anne M. Gillis, MD, FRCPC, Atul Verma, MD, FRCPC, Mario.

EFFECTS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS ON MORTALITY, CARDIOVASCULAR HOSPITALIZATION AND FUNCTIONAL CAPACITY IN PATIENTS WITH HEART.

Rick A. Nishimura et al. JACC 2017;70:

Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 1: Non-ST–Segment.

135 The Association Between Patterns of Myocardial Involvement and Clinical Presentation in Patients With Cardiac Sarcoidosis As Assessed By FDG-PET

The Clinical Significance and Management Implications of Chronic Total Occlusion Associated With Surgical Coronary Artery Revascularization Lorenzo Azzalini,

Volume 16, Issue 7, Pages (July 2019)

Mobile Medicine: Digital Dynamo or Virtual Vaporware

Targeted Therapeutic Drug Monitoring for Direct Oral Anticoagulants: What Is Its Potential Place and Can It Limit Black Swan Events? D. George Wyse,

Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older? Jean-Eric Tarride, PhD, F. Russell Quinn,

Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.

Presentation transcript:

Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Implementation Ratika Parkash, MD, MSc, François Philippon, MD, Miriam Shanks, MD, Bernard Thibault, MD, Jafna Cox, MD, Aaron Low, MD, Vidal Essebag, MD, PhD, Jamil Bashir, MD, Gordon Moe, MD, David H. Birnie, MD, Éric Larose, MD, Raymond Yee, MD, Elizabeth Swiggum, MD, Padma Kaul, PhD, Damian Redfearn, MD, Anthony S. Tang, MD, Derek V. Exner, MD, MPH Canadian Journal of Cardiology Volume 29, Issue 11, Pages 1346-1360 (November 2013) DOI: 10.1016/j.cjca.2013.09.009 Copyright © 2013 Canadian Cardiovascular Society Terms and Conditions

Figure 1 Evaluation of patients with a CIED and HF. CHF, congestive heart failure; CIED, cardiovascular implantable electronic device; CRT, cardiac resynchronization therapy; ECG, electrocardiogram; EF, ejection fraction; LV, left ventricular; NYHA, New York Heart Association; RV, right ventricular. Canadian Journal of Cardiology 2013 29, 1346-1360DOI: (10.1016/j.cjca.2013.09.009) Copyright © 2013 Canadian Cardiovascular Society Terms and Conditions

Figure 2 Follow-up and optimization of CRT delivery. AF, atrial fibrillation; CRT, cardiac resynchronization therapy; LV, left ventricular; PVC, premature ventricular contraction. Canadian Journal of Cardiology 2013 29, 1346-1360DOI: (10.1016/j.cjca.2013.09.009) Copyright © 2013 Canadian Cardiovascular Society Terms and Conditions

Figure 3 Evaluation process at the time of generator change. CRT, cardiac resynchronization therapy; CRT-D, CRT defibrillator; CRT-P, CRT pacemaker; LV, left ventricular; PG, pulse generator. Canadian Journal of Cardiology 2013 29, 1346-1360DOI: (10.1016/j.cjca.2013.09.009) Copyright © 2013 Canadian Cardiovascular Society Terms and Conditions